Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind Phase 3 study of terbinafine cream 1% vs Lamisil cream vs vehicle in tinea pedis
2008-004695-49Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Terbinafine in Athlete's foot (3 arms), sponsored by Dermapharm. Primary endpoint: Clinical and mycological treatment success at day 21. Started Oct 2008; status: completed.
02
Drugs
Terbinafine
03
Conditions
Athlete's foot
Beyond the preview
Go deeper on 2008-004695-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004695-49.